7Baggers

BioNexus Gene Lab Corp Quarterly Balance Sheets Chart

Quarterly
 | 
Annual
 
 Current Account Receivables  
 Current Account Payables  
20190331 20190630 20190930 20191231 20200331 20200630 20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 00.61.21.812.413.013.614.21Milllion

BioNexus Gene Lab Corp Quarterly Balance Sheets Table

Quarterly
 | 
Annual
 
Unit: USD2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 
  current account reveivables1,015,027 2,302,296 2,585,915 2,925,155 2,850,763 2,913,638 3,107,866 3,436,415 4,214,172 3,912,729 3,619,220 4,021,632 13,847 13,166 16,967 15,915 
  current account payables1,569,992 1,822,506 1,493,774 1,861,015 1,278,699 1,416,198 1,834,294 2,012,266 2,411,421 2,394,808 2,928,650 3,170,653 934 

We provide you with 20 years of balance sheets for BioNexus Gene Lab Corp stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of BioNexus Gene Lab Corp. Explore the full financial landscape of BioNexus Gene Lab Corp stock with our expertly curated balance sheets.

The information provided in this report about BioNexus Gene Lab Corp stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.